nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—Chloropyramine—Rosiglitazone—type 2 diabetes mellitus	0.165	1	CrCrCtD
Clomipramine—ADRA2A—type 2 diabetes mellitus	0.086	0.288	CbGaD
Clomipramine—HTR2C—type 2 diabetes mellitus	0.0791	0.265	CbGaD
Clomipramine—CYP1A2—type 2 diabetes mellitus	0.0597	0.2	CbGaD
Clomipramine—CYP3A4—type 2 diabetes mellitus	0.0395	0.132	CbGaD
Clomipramine—ALB—type 2 diabetes mellitus	0.0345	0.115	CbGaD
Clomipramine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0253	0.0749	CbGbCtD
Clomipramine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0226	0.0669	CbGbCtD
Clomipramine—ALB—Gliclazide—type 2 diabetes mellitus	0.0153	0.0453	CbGbCtD
Clomipramine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0147	0.0435	CbGbCtD
Clomipramine—ALB—Repaglinide—type 2 diabetes mellitus	0.0144	0.0426	CbGbCtD
Clomipramine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0133	0.0392	CbGbCtD
Clomipramine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0133	0.0392	CbGbCtD
Clomipramine—ALB—Rosiglitazone—type 2 diabetes mellitus	0.012	0.0356	CbGbCtD
Clomipramine—ALB—Valsartan—type 2 diabetes mellitus	0.0106	0.0314	CbGbCtD
Clomipramine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0106	0.0313	CbGbCtD
Clomipramine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00995	0.0294	CbGbCtD
Clomipramine—ALB—Nateglinide—type 2 diabetes mellitus	0.00989	0.0292	CbGbCtD
Clomipramine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00944	0.0279	CbGbCtD
Clomipramine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00846	0.025	CbGbCtD
Clomipramine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00846	0.025	CbGbCtD
Clomipramine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00781	0.0231	CbGbCtD
Clomipramine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00754	0.0223	CbGbCtD
Clomipramine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0072	0.0213	CbGbCtD
Clomipramine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00682	0.0202	CbGbCtD
Clomipramine—ALB—Glyburide—type 2 diabetes mellitus	0.00668	0.0197	CbGbCtD
Clomipramine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00643	0.019	CbGbCtD
Clomipramine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00635	0.0187	CbGbCtD
Clomipramine—ALB—Losartan—type 2 diabetes mellitus	0.00611	0.018	CbGbCtD
Clomipramine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00593	0.0175	CbGbCtD
Clomipramine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00567	0.0167	CbGbCtD
Clomipramine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00566	0.0167	CbGbCtD
Clomipramine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00536	0.0158	CbGbCtD
Clomipramine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00517	0.0153	CbGbCtD
Clomipramine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00487	0.0144	CbGbCtD
Clomipramine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00469	0.0138	CbGbCtD
Clomipramine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00467	0.0138	CbGbCtD
Clomipramine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00452	0.0134	CbGbCtD
Clomipramine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00433	0.0128	CbGbCtD
Clomipramine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00409	0.0121	CbGbCtD
Clomipramine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00396	0.0117	CbGbCtD
Clomipramine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00365	0.0108	CbGbCtD
Clomipramine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00349	0.0103	CbGbCtD
Clomipramine—ABCB1—Losartan—type 2 diabetes mellitus	0.0032	0.00944	CbGbCtD
Clomipramine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0031	0.00915	CbGbCtD
Clomipramine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00297	0.00877	CbGbCtD
Clomipramine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00297	0.00877	CbGbCtD
Clomipramine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00281	0.0083	CbGbCtD
Clomipramine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00209	0.00618	CbGbCtD
Clomipramine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00195	0.102	CbGeAlD
Clomipramine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00191	0.00565	CbGbCtD
Clomipramine—HTR2A—arteriole—type 2 diabetes mellitus	0.00184	0.0966	CbGeAlD
Clomipramine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00131	0.0689	CbGeAlD
Clomipramine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00117	0.0616	CbGeAlD
Clomipramine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000786	0.0414	CbGeAlD
Clomipramine—SLC6A2—nerve—type 2 diabetes mellitus	0.000736	0.0387	CbGeAlD
Clomipramine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000727	0.0383	CbGeAlD
Clomipramine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000667	0.0351	CbGeAlD
Clomipramine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000567	0.0299	CbGeAlD
Clomipramine—HRH2—cardiovascular system—type 2 diabetes mellitus	0.000489	0.0257	CbGeAlD
Clomipramine—GSTP1—islet of Langerhans—type 2 diabetes mellitus	0.000486	0.0256	CbGeAlD
Clomipramine—HTR2A—artery—type 2 diabetes mellitus	0.000446	0.0235	CbGeAlD
Clomipramine—HTR2A—nerve—type 2 diabetes mellitus	0.000442	0.0233	CbGeAlD
Clomipramine—GSTP1—retina—type 2 diabetes mellitus	0.000416	0.0219	CbGeAlD
Clomipramine—GSTP1—nephron tubule—type 2 diabetes mellitus	0.000392	0.0206	CbGeAlD
Clomipramine—HTR2A—endothelium—type 2 diabetes mellitus	0.000377	0.0198	CbGeAlD
Clomipramine—GSTP1—cardiovascular system—type 2 diabetes mellitus	0.000352	0.0185	CbGeAlD
Clomipramine—GSTP1—kidney—type 2 diabetes mellitus	0.000344	0.0181	CbGeAlD
Clomipramine—GSTP1—pancreas—type 2 diabetes mellitus	0.000342	0.018	CbGeAlD
Clomipramine—GSTP1—cortex of kidney—type 2 diabetes mellitus	0.000335	0.0176	CbGeAlD
Clomipramine—GSTP1—adipose tissue—type 2 diabetes mellitus	0.00031	0.0163	CbGeAlD
Clomipramine—HRH2—liver—type 2 diabetes mellitus	0.000302	0.0159	CbGeAlD
Clomipramine—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.00029	0.0153	CbGeAlD
Clomipramine—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000276	0.0146	CbGeAlD
Clomipramine—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000256	0.0135	CbGeAlD
Clomipramine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000252	0.0133	CbGeAlD
Clomipramine—GSTP1—liver—type 2 diabetes mellitus	0.000218	0.0115	CbGeAlD
Clomipramine—ALB—liver—type 2 diabetes mellitus	0.000186	0.00981	CbGeAlD
Clomipramine—HTR2A—retina—type 2 diabetes mellitus	0.000183	0.00964	CbGeAlD
Clomipramine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000177	0.00932	CbGeAlD
Clomipramine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000174	0.00914	CbGeAlD
Clomipramine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000161	0.00846	CbGeAlD
Clomipramine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000155	0.00815	CbGeAlD
Clomipramine—HTR2A—kidney—type 2 diabetes mellitus	0.000152	0.00798	CbGeAlD
Clomipramine—CYP2C19—liver—type 2 diabetes mellitus	0.00015	0.0079	CbGeAlD
Clomipramine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.00014	0.00739	CbGeAlD
Clomipramine—CYP3A4—kidney—type 2 diabetes mellitus	0.00014	0.00739	CbGeAlD
Clomipramine—CYP2D6—kidney—type 2 diabetes mellitus	0.000138	0.00727	CbGeAlD
Clomipramine—CYP1A2—liver—type 2 diabetes mellitus	0.000123	0.00645	CbGeAlD
Clomipramine—ABCB1—retina—type 2 diabetes mellitus	0.00012	0.00632	CbGeAlD
Clomipramine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000113	0.00595	CbGeAlD
Clomipramine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000102	0.00534	CbGeAlD
Clomipramine—ABCB1—kidney—type 2 diabetes mellitus	9.93e-05	0.00523	CbGeAlD
Clomipramine—ABCB1—pancreas—type 2 diabetes mellitus	9.87e-05	0.00519	CbGeAlD
Clomipramine—ABCB1—cortex of kidney—type 2 diabetes mellitus	9.67e-05	0.00509	CbGeAlD
Clomipramine—HTR2A—liver—type 2 diabetes mellitus	9.58e-05	0.00504	CbGeAlD
Clomipramine—Propericiazine—ADRA2A—type 2 diabetes mellitus	9.39e-05	0.0361	CrCbGaD
Clomipramine—Promethazine—CALM1—type 2 diabetes mellitus	8.97e-05	0.0345	CrCbGaD
Clomipramine—ABCB1—adipose tissue—type 2 diabetes mellitus	8.95e-05	0.00471	CbGeAlD
Clomipramine—CYP3A4—liver—type 2 diabetes mellitus	8.87e-05	0.00467	CbGeAlD
Clomipramine—Trifluoperazine—CALM1—type 2 diabetes mellitus	8.85e-05	0.0341	CrCbGaD
Clomipramine—Perphenazine—CALM1—type 2 diabetes mellitus	8.76e-05	0.0337	CrCbGaD
Clomipramine—CYP2D6—liver—type 2 diabetes mellitus	8.73e-05	0.00459	CbGeAlD
Clomipramine—Cyamemazine—HTR2C—type 2 diabetes mellitus	8.64e-05	0.0333	CrCbGaD
Clomipramine—Chlorpromazine—CALM1—type 2 diabetes mellitus	6.95e-05	0.0267	CrCbGaD
Clomipramine—ABCB1—liver—type 2 diabetes mellitus	6.28e-05	0.0033	CbGeAlD
Clomipramine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	5.24e-05	0.0202	CrCbGaD
Clomipramine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	5.1e-05	0.0196	CrCbGaD
Clomipramine—Olopatadine—CYP3A4—type 2 diabetes mellitus	4.77e-05	0.0184	CrCbGaD
Clomipramine—Propiomazine—HTR2C—type 2 diabetes mellitus	4.44e-05	0.0171	CrCbGaD
Clomipramine—Alimemazine—CYP3A4—type 2 diabetes mellitus	4.36e-05	0.0168	CrCbGaD
Clomipramine—Thioridazine—ADRA2A—type 2 diabetes mellitus	4.32e-05	0.0166	CrCbGaD
Clomipramine—Trimipramine—ADRA2A—type 2 diabetes mellitus	4.22e-05	0.0162	CrCbGaD
Clomipramine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	4.2e-05	0.0162	CrCbGaD
Clomipramine—Nortriptyline—HTR2C—type 2 diabetes mellitus	4.12e-05	0.0159	CrCbGaD
Clomipramine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	4.12e-05	0.0159	CrCbGaD
Clomipramine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	4.03e-05	0.0155	CrCbGaD
Clomipramine—Doxepin—ADRA2A—type 2 diabetes mellitus	4.02e-05	0.0155	CrCbGaD
Clomipramine—Thioridazine—HTR2C—type 2 diabetes mellitus	3.98e-05	0.0153	CrCbGaD
Clomipramine—Perphenazine—ADRA2A—type 2 diabetes mellitus	3.96e-05	0.0152	CrCbGaD
Clomipramine—Trimipramine—HTR2C—type 2 diabetes mellitus	3.88e-05	0.0149	CrCbGaD
Clomipramine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	3.8e-05	0.0146	CrCbGaD
Clomipramine—Doxepin—HTR2C—type 2 diabetes mellitus	3.7e-05	0.0142	CrCbGaD
Clomipramine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	3.69e-05	0.0142	CrCbGaD
Clomipramine—Perphenazine—HTR2C—type 2 diabetes mellitus	3.65e-05	0.014	CrCbGaD
Clomipramine—Anxiety—Irbesartan—type 2 diabetes mellitus	3.63e-05	0.000313	CcSEcCtD
Clomipramine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	3.63e-05	0.000313	CcSEcCtD
Clomipramine—Nervous system disorder—Metformin—type 2 diabetes mellitus	3.63e-05	0.000313	CcSEcCtD
Clomipramine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	3.62e-05	0.000312	CcSEcCtD
Clomipramine—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.62e-05	0.000312	CcSEcCtD
Clomipramine—Vertigo—Losartan—type 2 diabetes mellitus	3.61e-05	0.000312	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.61e-05	0.000312	CcSEcCtD
Clomipramine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.61e-05	0.000312	CcSEcCtD
Clomipramine—Somnolence—Valsartan—type 2 diabetes mellitus	3.61e-05	0.000312	CcSEcCtD
Clomipramine—Syncope—Losartan—type 2 diabetes mellitus	3.61e-05	0.000311	CcSEcCtD
Clomipramine—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.6e-05	0.000311	CcSEcCtD
Clomipramine—Leukopenia—Losartan—type 2 diabetes mellitus	3.6e-05	0.000311	CcSEcCtD
Clomipramine—Discomfort—Irbesartan—type 2 diabetes mellitus	3.6e-05	0.00031	CcSEcCtD
Clomipramine—Skin disorder—Metformin—type 2 diabetes mellitus	3.59e-05	0.00031	CcSEcCtD
Clomipramine—Immune system disorder—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000309	CcSEcCtD
Clomipramine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.57e-05	0.000309	CcSEcCtD
Clomipramine—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.57e-05	0.000308	CcSEcCtD
Clomipramine—Promazine—ADRA2A—type 2 diabetes mellitus	3.57e-05	0.0137	CrCbGaD
Clomipramine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000308	CcSEcCtD
Clomipramine—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.56e-05	0.000307	CcSEcCtD
Clomipramine—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.000307	CcSEcCtD
Clomipramine—Palpitations—Losartan—type 2 diabetes mellitus	3.55e-05	0.000307	CcSEcCtD
Clomipramine—Nausea—Glimepiride—type 2 diabetes mellitus	3.54e-05	0.000306	CcSEcCtD
Clomipramine—Arrhythmia—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000306	CcSEcCtD
Clomipramine—Loss of consciousness—Losartan—type 2 diabetes mellitus	3.54e-05	0.000305	CcSEcCtD
Clomipramine—Nausea—Sitagliptin—type 2 diabetes mellitus	3.53e-05	0.000305	CcSEcCtD
Clomipramine—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.53e-05	0.000305	CcSEcCtD
Clomipramine—Asthenia—Glyburide—type 2 diabetes mellitus	3.53e-05	0.000305	CcSEcCtD
Clomipramine—Decreased appetite—Valsartan—type 2 diabetes mellitus	3.53e-05	0.000305	CcSEcCtD
Clomipramine—Anorexia—Metformin—type 2 diabetes mellitus	3.52e-05	0.000304	CcSEcCtD
Clomipramine—Cough—Losartan—type 2 diabetes mellitus	3.51e-05	0.000303	CcSEcCtD
Clomipramine—Urticaria—Gliclazide—type 2 diabetes mellitus	3.51e-05	0.000303	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.5e-05	0.000303	CcSEcCtD
Clomipramine—Alopecia—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000302	CcSEcCtD
Clomipramine—Fatigue—Valsartan—type 2 diabetes mellitus	3.5e-05	0.000302	CcSEcCtD
Clomipramine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.49e-05	0.000302	CcSEcCtD
Clomipramine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.49e-05	0.000302	CcSEcCtD
Clomipramine—Oedema—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000301	CcSEcCtD
Clomipramine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000301	CcSEcCtD
Clomipramine—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.49e-05	0.000301	CcSEcCtD
Clomipramine—Pruritus—Glyburide—type 2 diabetes mellitus	3.48e-05	0.000301	CcSEcCtD
Clomipramine—Mental disorder—Ramipril—type 2 diabetes mellitus	3.47e-05	0.0003	CcSEcCtD
Clomipramine—Constipation—Valsartan—type 2 diabetes mellitus	3.47e-05	0.0003	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.46e-05	0.000299	CcSEcCtD
Clomipramine—Fatigue—Orlistat—type 2 diabetes mellitus	3.46e-05	0.000299	CcSEcCtD
Clomipramine—Hypotension—Metformin—type 2 diabetes mellitus	3.45e-05	0.000298	CcSEcCtD
Clomipramine—Malnutrition—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000298	CcSEcCtD
Clomipramine—Shock—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000296	CcSEcCtD
Clomipramine—Pain—Orlistat—type 2 diabetes mellitus	3.43e-05	0.000296	CcSEcCtD
Clomipramine—Arthralgia—Losartan—type 2 diabetes mellitus	3.42e-05	0.000296	CcSEcCtD
Clomipramine—Chest pain—Losartan—type 2 diabetes mellitus	3.42e-05	0.000296	CcSEcCtD
Clomipramine—Myalgia—Losartan—type 2 diabetes mellitus	3.42e-05	0.000296	CcSEcCtD
Clomipramine—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.42e-05	0.000295	CcSEcCtD
Clomipramine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	3.42e-05	0.000295	CcSEcCtD
Clomipramine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.42e-05	0.000295	CcSEcCtD
Clomipramine—Anxiety—Losartan—type 2 diabetes mellitus	3.41e-05	0.000295	CcSEcCtD
Clomipramine—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.4e-05	0.000294	CcSEcCtD
Clomipramine—Desipramine—HTR2C—type 2 diabetes mellitus	3.4e-05	0.0131	CrCbGaD
Clomipramine—Rash—Bromocriptine—type 2 diabetes mellitus	3.39e-05	0.000293	CcSEcCtD
Clomipramine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.39e-05	0.000293	CcSEcCtD
Clomipramine—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000293	CcSEcCtD
Clomipramine—Tension—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000292	CcSEcCtD
Clomipramine—Discomfort—Losartan—type 2 diabetes mellitus	3.38e-05	0.000292	CcSEcCtD
Clomipramine—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000292	CcSEcCtD
Clomipramine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000291	CcSEcCtD
Clomipramine—Headache—Bromocriptine—type 2 diabetes mellitus	3.37e-05	0.000291	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.37e-05	0.000291	CcSEcCtD
Clomipramine—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.37e-05	0.000291	CcSEcCtD
Clomipramine—Nervousness—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000289	CcSEcCtD
Clomipramine—Dry mouth—Losartan—type 2 diabetes mellitus	3.35e-05	0.000289	CcSEcCtD
Clomipramine—Anorexia—Irbesartan—type 2 diabetes mellitus	3.33e-05	0.000287	CcSEcCtD
Clomipramine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.32e-05	0.000287	CcSEcCtD
Clomipramine—Paraesthesia—Metformin—type 2 diabetes mellitus	3.32e-05	0.000287	CcSEcCtD
Clomipramine—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000286	CcSEcCtD
Clomipramine—Confusional state—Losartan—type 2 diabetes mellitus	3.31e-05	0.000286	CcSEcCtD
Clomipramine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.31e-05	0.000285	CcSEcCtD
Clomipramine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	3.3e-05	0.0127	CrCbGaD
Clomipramine—Dyspnoea—Metformin—type 2 diabetes mellitus	3.3e-05	0.000285	CcSEcCtD
Clomipramine—Promazine—HTR2C—type 2 diabetes mellitus	3.29e-05	0.0127	CrCbGaD
Clomipramine—Somnolence—Metformin—type 2 diabetes mellitus	3.29e-05	0.000284	CcSEcCtD
Clomipramine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3.28e-05	0.000283	CcSEcCtD
Clomipramine—Oedema—Losartan—type 2 diabetes mellitus	3.28e-05	0.000283	CcSEcCtD
Clomipramine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.28e-05	0.000283	CcSEcCtD
Clomipramine—Nortriptyline—CYP2E1—type 2 diabetes mellitus	3.27e-05	0.0126	CrCbGaD
Clomipramine—Hypotension—Irbesartan—type 2 diabetes mellitus	3.26e-05	0.000281	CcSEcCtD
Clomipramine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.26e-05	0.000281	CcSEcCtD
Clomipramine—Dyspepsia—Metformin—type 2 diabetes mellitus	3.25e-05	0.000281	CcSEcCtD
Clomipramine—Tremor—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000279	CcSEcCtD
Clomipramine—Shock—Losartan—type 2 diabetes mellitus	3.23e-05	0.000279	CcSEcCtD
Clomipramine—Urticaria—Valsartan—type 2 diabetes mellitus	3.22e-05	0.000278	CcSEcCtD
Clomipramine—Nervous system disorder—Losartan—type 2 diabetes mellitus	3.22e-05	0.000278	CcSEcCtD
Clomipramine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.21e-05	0.000278	CcSEcCtD
Clomipramine—Decreased appetite—Metformin—type 2 diabetes mellitus	3.21e-05	0.000277	CcSEcCtD
Clomipramine—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.21e-05	0.000277	CcSEcCtD
Clomipramine—Tachycardia—Losartan—type 2 diabetes mellitus	3.2e-05	0.000277	CcSEcCtD
Clomipramine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000276	CcSEcCtD
Clomipramine—Nausea—Bromocriptine—type 2 diabetes mellitus	3.2e-05	0.000276	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.19e-05	0.000276	CcSEcCtD
Clomipramine—Fatigue—Metformin—type 2 diabetes mellitus	3.19e-05	0.000275	CcSEcCtD
Clomipramine—Urticaria—Orlistat—type 2 diabetes mellitus	3.19e-05	0.000275	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.18e-05	0.000274	CcSEcCtD
Clomipramine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.17e-05	0.000274	CcSEcCtD
Clomipramine—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.17e-05	0.000274	CcSEcCtD
Clomipramine—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.17e-05	0.000274	CcSEcCtD
Clomipramine—Asthenia—Gliclazide—type 2 diabetes mellitus	3.17e-05	0.000274	CcSEcCtD
Clomipramine—Agitation—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000274	CcSEcCtD
Clomipramine—Constipation—Metformin—type 2 diabetes mellitus	3.16e-05	0.000273	CcSEcCtD
Clomipramine—Thioridazine—CYP2E1—type 2 diabetes mellitus	3.15e-05	0.0121	CrCbGaD
Clomipramine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	3.14e-05	0.0121	CrCbGaD
Clomipramine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.13e-05	0.00027	CcSEcCtD
Clomipramine—Anorexia—Losartan—type 2 diabetes mellitus	3.13e-05	0.00027	CcSEcCtD
Clomipramine—Vomiting—Glyburide—type 2 diabetes mellitus	3.13e-05	0.00027	CcSEcCtD
Clomipramine—Pruritus—Gliclazide—type 2 diabetes mellitus	3.13e-05	0.00027	CcSEcCtD
Clomipramine—Flurazepam—CYP2E1—type 2 diabetes mellitus	3.11e-05	0.012	CrCbGaD
Clomipramine—Nortriptyline—CYP1A2—type 2 diabetes mellitus	3.11e-05	0.012	CrCbGaD
Clomipramine—Malaise—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000269	CcSEcCtD
Clomipramine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.11e-05	0.000268	CcSEcCtD
Clomipramine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	3.11e-05	0.012	CrCbGaD
Clomipramine—Rash—Glyburide—type 2 diabetes mellitus	3.1e-05	0.000268	CcSEcCtD
Clomipramine—Somnolence—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.000268	CcSEcCtD
Clomipramine—Dermatitis—Glyburide—type 2 diabetes mellitus	3.1e-05	0.000268	CcSEcCtD
Clomipramine—Vertigo—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000268	CcSEcCtD
Clomipramine—Syncope—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000267	CcSEcCtD
Clomipramine—Leukopenia—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000267	CcSEcCtD
Clomipramine—Headache—Glyburide—type 2 diabetes mellitus	3.08e-05	0.000266	CcSEcCtD
Clomipramine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.07e-05	0.000265	CcSEcCtD
Clomipramine—Hypotension—Losartan—type 2 diabetes mellitus	3.07e-05	0.000265	CcSEcCtD
Clomipramine—Palpitations—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000263	CcSEcCtD
Clomipramine—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.05e-05	0.000263	CcSEcCtD
Clomipramine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.03e-05	0.000262	CcSEcCtD
Clomipramine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000262	CcSEcCtD
Clomipramine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.02e-05	0.000261	CcSEcCtD
Clomipramine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.02e-05	0.000261	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.01e-05	0.00026	CcSEcCtD
Clomipramine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	3.01e-05	0.0116	CrCbGaD
Clomipramine—Cough—Ramipril—type 2 diabetes mellitus	3.01e-05	0.00026	CcSEcCtD
Clomipramine—Fatigue—Irbesartan—type 2 diabetes mellitus	3.01e-05	0.00026	CcSEcCtD
Clomipramine—Thioridazine—CYP1A2—type 2 diabetes mellitus	3e-05	0.0115	CrCbGaD
Clomipramine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.99e-05	0.000258	CcSEcCtD
Clomipramine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	2.99e-05	0.000258	CcSEcCtD
Clomipramine—Convulsion—Ramipril—type 2 diabetes mellitus	2.99e-05	0.000258	CcSEcCtD
Clomipramine—Pain—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000258	CcSEcCtD
Clomipramine—Constipation—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000258	CcSEcCtD
Clomipramine—Insomnia—Losartan—type 2 diabetes mellitus	2.97e-05	0.000256	CcSEcCtD
Clomipramine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	2.96e-05	0.000255	CcSEcCtD
Clomipramine—Paraesthesia—Losartan—type 2 diabetes mellitus	2.95e-05	0.000254	CcSEcCtD
Clomipramine—Urticaria—Metformin—type 2 diabetes mellitus	2.94e-05	0.000254	CcSEcCtD
Clomipramine—Arthralgia—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000254	CcSEcCtD
Clomipramine—Chest pain—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000254	CcSEcCtD
Clomipramine—Myalgia—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000254	CcSEcCtD
Clomipramine—Dyspnoea—Losartan—type 2 diabetes mellitus	2.93e-05	0.000253	CcSEcCtD
Clomipramine—Anxiety—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000253	CcSEcCtD
Clomipramine—Nausea—Glyburide—type 2 diabetes mellitus	2.92e-05	0.000252	CcSEcCtD
Clomipramine—Abdominal pain—Metformin—type 2 diabetes mellitus	2.92e-05	0.000252	CcSEcCtD
Clomipramine—Dizziness—Gliclazide—type 2 diabetes mellitus	2.92e-05	0.000252	CcSEcCtD
Clomipramine—Somnolence—Losartan—type 2 diabetes mellitus	2.92e-05	0.000252	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000252	CcSEcCtD
Clomipramine—Asthenia—Valsartan—type 2 diabetes mellitus	2.91e-05	0.000251	CcSEcCtD
Clomipramine—Discomfort—Ramipril—type 2 diabetes mellitus	2.9e-05	0.00025	CcSEcCtD
Clomipramine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	2.89e-05	0.0111	CrCbGaD
Clomipramine—Dyspepsia—Losartan—type 2 diabetes mellitus	2.89e-05	0.000249	CcSEcCtD
Clomipramine—Imipramine—HTR2C—type 2 diabetes mellitus	2.88e-05	0.0111	CrCbGaD
Clomipramine—Asthenia—Orlistat—type 2 diabetes mellitus	2.88e-05	0.000248	CcSEcCtD
Clomipramine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.000248	CcSEcCtD
Clomipramine—Pruritus—Valsartan—type 2 diabetes mellitus	2.87e-05	0.000248	CcSEcCtD
Clomipramine—Dry mouth—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000248	CcSEcCtD
Clomipramine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	2.86e-05	0.011	CrCbGaD
Clomipramine—Amitriptyline—HTR2C—type 2 diabetes mellitus	2.86e-05	0.011	CrCbGaD
Clomipramine—Decreased appetite—Losartan—type 2 diabetes mellitus	2.85e-05	0.000246	CcSEcCtD
Clomipramine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.85e-05	0.000246	CcSEcCtD
Clomipramine—Confusional state—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000245	CcSEcCtD
Clomipramine—Pruritus—Orlistat—type 2 diabetes mellitus	2.84e-05	0.000245	CcSEcCtD
Clomipramine—Fatigue—Losartan—type 2 diabetes mellitus	2.83e-05	0.000244	CcSEcCtD
Clomipramine—Oedema—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000243	CcSEcCtD
Clomipramine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000243	CcSEcCtD
Clomipramine—Vomiting—Gliclazide—type 2 diabetes mellitus	2.81e-05	0.000243	CcSEcCtD
Clomipramine—Pain—Losartan—type 2 diabetes mellitus	2.81e-05	0.000242	CcSEcCtD
Clomipramine—Constipation—Losartan—type 2 diabetes mellitus	2.81e-05	0.000242	CcSEcCtD
Clomipramine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	2.81e-05	0.0108	CrCbGaD
Clomipramine—Doxepin—CYP1A2—type 2 diabetes mellitus	2.79e-05	0.0107	CrCbGaD
Clomipramine—Rash—Gliclazide—type 2 diabetes mellitus	2.79e-05	0.00024	CcSEcCtD
Clomipramine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	2.78e-05	0.0107	CrCbGaD
Clomipramine—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.78e-05	0.00024	CcSEcCtD
Clomipramine—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.78e-05	0.00024	CcSEcCtD
Clomipramine—Urticaria—Irbesartan—type 2 diabetes mellitus	2.77e-05	0.000239	CcSEcCtD
Clomipramine—Shock—Ramipril—type 2 diabetes mellitus	2.77e-05	0.000239	CcSEcCtD
Clomipramine—Headache—Gliclazide—type 2 diabetes mellitus	2.77e-05	0.000239	CcSEcCtD
Clomipramine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000238	CcSEcCtD
Clomipramine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.000238	CcSEcCtD
Clomipramine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.000238	CcSEcCtD
Clomipramine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000238	CcSEcCtD
Clomipramine—Perphenazine—CYP1A2—type 2 diabetes mellitus	2.75e-05	0.0106	CrCbGaD
Clomipramine—Tachycardia—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000237	CcSEcCtD
Clomipramine—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.74e-05	0.000237	CcSEcCtD
Clomipramine—Skin disorder—Ramipril—type 2 diabetes mellitus	2.73e-05	0.000236	CcSEcCtD
Clomipramine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000235	CcSEcCtD
Clomipramine—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.71e-05	0.000234	CcSEcCtD
Clomipramine—Desipramine—CYP2E1—type 2 diabetes mellitus	2.69e-05	0.0104	CrCbGaD
Clomipramine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.68e-05	0.000232	CcSEcCtD
Clomipramine—Dizziness—Valsartan—type 2 diabetes mellitus	2.68e-05	0.000232	CcSEcCtD
Clomipramine—Anorexia—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000232	CcSEcCtD
Clomipramine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	2.67e-05	0.0103	CrCbGaD
Clomipramine—Clobazam—CYP3A4—type 2 diabetes mellitus	2.67e-05	0.0103	CrCbGaD
Clomipramine—Dizziness—Orlistat—type 2 diabetes mellitus	2.65e-05	0.000229	CcSEcCtD
Clomipramine—Asthenia—Metformin—type 2 diabetes mellitus	2.65e-05	0.000229	CcSEcCtD
Clomipramine—Hypotension—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000227	CcSEcCtD
Clomipramine—Nausea—Gliclazide—type 2 diabetes mellitus	2.62e-05	0.000227	CcSEcCtD
Clomipramine—Pruritus—Metformin—type 2 diabetes mellitus	2.62e-05	0.000226	CcSEcCtD
Clomipramine—Urticaria—Losartan—type 2 diabetes mellitus	2.61e-05	0.000225	CcSEcCtD
Clomipramine—Body temperature increased—Losartan—type 2 diabetes mellitus	2.6e-05	0.000224	CcSEcCtD
Clomipramine—Abdominal pain—Losartan—type 2 diabetes mellitus	2.6e-05	0.000224	CcSEcCtD
Clomipramine—Vomiting—Valsartan—type 2 diabetes mellitus	2.58e-05	0.000223	CcSEcCtD
Clomipramine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.57e-05	0.000222	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.56e-05	0.000221	CcSEcCtD
Clomipramine—Desipramine—CYP1A2—type 2 diabetes mellitus	2.56e-05	0.00986	CrCbGaD
Clomipramine—Rash—Valsartan—type 2 diabetes mellitus	2.56e-05	0.000221	CcSEcCtD
Clomipramine—Dermatitis—Valsartan—type 2 diabetes mellitus	2.56e-05	0.000221	CcSEcCtD
Clomipramine—Vomiting—Orlistat—type 2 diabetes mellitus	2.55e-05	0.00022	CcSEcCtD
Clomipramine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	2.55e-05	0.00981	CrCbGaD
Clomipramine—Insomnia—Ramipril—type 2 diabetes mellitus	2.55e-05	0.00022	CcSEcCtD
Clomipramine—Headache—Valsartan—type 2 diabetes mellitus	2.54e-05	0.00022	CcSEcCtD
Clomipramine—Diarrhoea—Metformin—type 2 diabetes mellitus	2.53e-05	0.000218	CcSEcCtD
Clomipramine—Rash—Orlistat—type 2 diabetes mellitus	2.53e-05	0.000218	CcSEcCtD
Clomipramine—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.53e-05	0.000218	CcSEcCtD
Clomipramine—Dermatitis—Orlistat—type 2 diabetes mellitus	2.53e-05	0.000218	CcSEcCtD
Clomipramine—Headache—Orlistat—type 2 diabetes mellitus	2.51e-05	0.000217	CcSEcCtD
Clomipramine—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.51e-05	0.000217	CcSEcCtD
Clomipramine—Asthenia—Irbesartan—type 2 diabetes mellitus	2.5e-05	0.000216	CcSEcCtD
Clomipramine—Somnolence—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000216	CcSEcCtD
Clomipramine—Promazine—CYP1A2—type 2 diabetes mellitus	2.48e-05	0.00955	CrCbGaD
Clomipramine—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000214	CcSEcCtD
Clomipramine—Diazepam—CYP2E1—type 2 diabetes mellitus	2.47e-05	0.00951	CrCbGaD
Clomipramine—Pruritus—Irbesartan—type 2 diabetes mellitus	2.47e-05	0.000213	CcSEcCtD
Clomipramine—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000211	CcSEcCtD
Clomipramine—Dizziness—Metformin—type 2 diabetes mellitus	2.44e-05	0.000211	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.43e-05	0.00021	CcSEcCtD
Clomipramine—Fatigue—Ramipril—type 2 diabetes mellitus	2.43e-05	0.00021	CcSEcCtD
Clomipramine—Acepromazine—ALB—type 2 diabetes mellitus	2.42e-05	0.00931	CrCbGaD
Clomipramine—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.42e-05	0.000209	CcSEcCtD
Clomipramine—Nausea—Valsartan—type 2 diabetes mellitus	2.41e-05	0.000208	CcSEcCtD
Clomipramine—Constipation—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000208	CcSEcCtD
Clomipramine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.39e-05	0.000206	CcSEcCtD
Clomipramine—Nausea—Orlistat—type 2 diabetes mellitus	2.38e-05	0.000206	CcSEcCtD
Clomipramine—Thioproperazine—ALB—type 2 diabetes mellitus	2.36e-05	0.0091	CrCbGaD
Clomipramine—Asthenia—Losartan—type 2 diabetes mellitus	2.36e-05	0.000203	CcSEcCtD
Clomipramine—Diazepam—CYP1A2—type 2 diabetes mellitus	2.35e-05	0.00905	CrCbGaD
Clomipramine—Vomiting—Metformin—type 2 diabetes mellitus	2.35e-05	0.000203	CcSEcCtD
Clomipramine—Rash—Metformin—type 2 diabetes mellitus	2.33e-05	0.000201	CcSEcCtD
Clomipramine—Dermatitis—Metformin—type 2 diabetes mellitus	2.33e-05	0.000201	CcSEcCtD
Clomipramine—Pipotiazine—ALB—type 2 diabetes mellitus	2.33e-05	0.00895	CrCbGaD
Clomipramine—Pruritus—Losartan—type 2 diabetes mellitus	2.32e-05	0.000201	CcSEcCtD
Clomipramine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.32e-05	0.0002	CcSEcCtD
Clomipramine—Headache—Metformin—type 2 diabetes mellitus	2.32e-05	0.0002	CcSEcCtD
Clomipramine—Dizziness—Irbesartan—type 2 diabetes mellitus	2.31e-05	0.000199	CcSEcCtD
Clomipramine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.3e-05	0.000199	CcSEcCtD
Clomipramine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	2.3e-05	0.00883	CrCbGaD
Clomipramine—Imipramine—CYP2E1—type 2 diabetes mellitus	2.28e-05	0.00879	CrCbGaD
Clomipramine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	2.27e-05	0.00873	CrCbGaD
Clomipramine—Diarrhoea—Losartan—type 2 diabetes mellitus	2.25e-05	0.000194	CcSEcCtD
Clomipramine—Urticaria—Ramipril—type 2 diabetes mellitus	2.24e-05	0.000193	CcSEcCtD
Clomipramine—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000192	CcSEcCtD
Clomipramine—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000192	CcSEcCtD
Clomipramine—Vomiting—Irbesartan—type 2 diabetes mellitus	2.22e-05	0.000191	CcSEcCtD
Clomipramine—Rash—Irbesartan—type 2 diabetes mellitus	2.2e-05	0.00019	CcSEcCtD
Clomipramine—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.2e-05	0.00019	CcSEcCtD
Clomipramine—Nausea—Metformin—type 2 diabetes mellitus	2.2e-05	0.00019	CcSEcCtD
Clomipramine—Headache—Irbesartan—type 2 diabetes mellitus	2.19e-05	0.000189	CcSEcCtD
Clomipramine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	2.18e-05	0.0084	CrCbGaD
Clomipramine—Adinazolam—CYP3A4—type 2 diabetes mellitus	2.17e-05	0.00837	CrCbGaD
Clomipramine—Imipramine—CYP1A2—type 2 diabetes mellitus	2.17e-05	0.00836	CrCbGaD
Clomipramine—Dizziness—Losartan—type 2 diabetes mellitus	2.17e-05	0.000187	CcSEcCtD
Clomipramine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	2.16e-05	0.00831	CrCbGaD
Clomipramine—Vomiting—Losartan—type 2 diabetes mellitus	2.09e-05	0.00018	CcSEcCtD
Clomipramine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.07e-05	0.000179	CcSEcCtD
Clomipramine—Nausea—Irbesartan—type 2 diabetes mellitus	2.07e-05	0.000179	CcSEcCtD
Clomipramine—Rash—Losartan—type 2 diabetes mellitus	2.07e-05	0.000179	CcSEcCtD
Clomipramine—Dermatitis—Losartan—type 2 diabetes mellitus	2.07e-05	0.000179	CcSEcCtD
Clomipramine—Nortriptyline—CYP3A4—type 2 diabetes mellitus	2.06e-05	0.00793	CrCbGaD
Clomipramine—Headache—Losartan—type 2 diabetes mellitus	2.06e-05	0.000178	CcSEcCtD
Clomipramine—Asthenia—Ramipril—type 2 diabetes mellitus	2.02e-05	0.000174	CcSEcCtD
Clomipramine—Pruritus—Ramipril—type 2 diabetes mellitus	1.99e-05	0.000172	CcSEcCtD
Clomipramine—Flurazepam—CYP3A4—type 2 diabetes mellitus	1.96e-05	0.00754	CrCbGaD
Clomipramine—Nausea—Losartan—type 2 diabetes mellitus	1.95e-05	0.000168	CcSEcCtD
Clomipramine—Trimipramine—CYP3A4—type 2 diabetes mellitus	1.94e-05	0.00746	CrCbGaD
Clomipramine—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.93e-05	0.000166	CcSEcCtD
Clomipramine—Dizziness—Ramipril—type 2 diabetes mellitus	1.86e-05	0.000161	CcSEcCtD
Clomipramine—Doxepin—CYP3A4—type 2 diabetes mellitus	1.85e-05	0.00711	CrCbGaD
Clomipramine—Perphenazine—CYP3A4—type 2 diabetes mellitus	1.82e-05	0.00701	CrCbGaD
Clomipramine—Nortriptyline—ALB—type 2 diabetes mellitus	1.8e-05	0.00692	CrCbGaD
Clomipramine—Vomiting—Ramipril—type 2 diabetes mellitus	1.79e-05	0.000155	CcSEcCtD
Clomipramine—Rash—Ramipril—type 2 diabetes mellitus	1.77e-05	0.000153	CcSEcCtD
Clomipramine—Dermatitis—Ramipril—type 2 diabetes mellitus	1.77e-05	0.000153	CcSEcCtD
Clomipramine—Headache—Ramipril—type 2 diabetes mellitus	1.76e-05	0.000152	CcSEcCtD
Clomipramine—Desipramine—CYP3A4—type 2 diabetes mellitus	1.7e-05	0.00653	CrCbGaD
Clomipramine—Nausea—Ramipril—type 2 diabetes mellitus	1.67e-05	0.000144	CcSEcCtD
Clomipramine—Promazine—CYP3A4—type 2 diabetes mellitus	1.64e-05	0.00632	CrCbGaD
Clomipramine—Diazepam—CYP3A4—type 2 diabetes mellitus	1.56e-05	0.00599	CrCbGaD
Clomipramine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	1.45e-05	0.00556	CrCbGaD
Clomipramine—Imipramine—CYP3A4—type 2 diabetes mellitus	1.44e-05	0.00554	CrCbGaD
Clomipramine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	1.43e-05	0.0055	CrCbGaD
Clomipramine—Diazepam—ALB—type 2 diabetes mellitus	1.36e-05	0.00523	CrCbGaD
Clomipramine—Chlorpromazine—ALB—type 2 diabetes mellitus	1.26e-05	0.00485	CrCbGaD
Clomipramine—Amitriptyline—ALB—type 2 diabetes mellitus	1.25e-05	0.0048	CrCbGaD
Clomipramine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.88e-06	3.13e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	1.88e-06	3.12e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.88e-06	3.12e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.87e-06	3.11e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.86e-06	3.1e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.86e-06	3.1e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.86e-06	3.09e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.85e-06	3.07e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.84e-06	3.07e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.84e-06	3.07e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.84e-06	3.07e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.84e-06	3.07e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	3.06e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.84e-06	3.06e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.84e-06	3.06e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.84e-06	3.06e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.84e-06	3.06e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.83e-06	3.05e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	1.83e-06	3.05e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.83e-06	3.05e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	1.83e-06	3.04e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.82e-06	3.03e-05	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.82e-06	3.02e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.81e-06	3.02e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.81e-06	3.01e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.81e-06	3.01e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.81e-06	3.01e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.81e-06	3.01e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.81e-06	3.01e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.81e-06	3.01e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.8e-06	3e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.8e-06	3e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.8e-06	2.99e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.8e-06	2.99e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.8e-06	2.99e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.8e-06	2.99e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PPARA—type 2 diabetes mellitus	1.79e-06	2.98e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.79e-06	2.98e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.79e-06	2.97e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.78e-06	2.97e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	1.78e-06	2.97e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.78e-06	2.97e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.78e-06	2.96e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.78e-06	2.96e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.77e-06	2.94e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.76e-06	2.92e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.75e-06	2.92e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.74e-06	2.9e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AGT—type 2 diabetes mellitus	1.74e-06	2.89e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.73e-06	2.89e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.73e-06	2.88e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.73e-06	2.88e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SRC—type 2 diabetes mellitus	1.72e-06	2.86e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.71e-06	2.84e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.71e-06	2.84e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.71e-06	2.84e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CALM1—type 2 diabetes mellitus	1.71e-06	2.84e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.71e-06	2.84e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—type 2 diabetes mellitus	1.7e-06	2.83e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.7e-06	2.83e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.7e-06	2.83e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.69e-06	2.82e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.69e-06	2.81e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.69e-06	2.81e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.68e-06	2.8e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOA1—type 2 diabetes mellitus	1.68e-06	2.8e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.68e-06	2.79e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.67e-06	2.78e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.67e-06	2.78e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.67e-06	2.77e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.65e-06	2.74e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.64e-06	2.73e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.64e-06	2.73e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.64e-06	2.72e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.64e-06	2.72e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.63e-06	2.72e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.63e-06	2.71e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-06	2.69e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-06	2.69e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.61e-06	2.68e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.61e-06	2.68e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.61e-06	2.68e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.61e-06	2.68e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.61e-06	2.68e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.61e-06	2.68e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.6e-06	2.66e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.59e-06	2.65e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.58e-06	2.63e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.57e-06	2.62e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.57e-06	2.61e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.57e-06	2.61e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.57e-06	2.61e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.56e-06	2.59e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.56e-06	2.59e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.56e-06	2.59e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.55e-06	2.59e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.55e-06	2.58e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.54e-06	2.56e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.53e-06	2.55e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.53e-06	2.55e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.53e-06	2.55e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.53e-06	2.55e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.53e-06	2.54e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.53e-06	2.54e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.52e-06	2.53e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.52e-06	2.52e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.51e-06	2.51e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.51e-06	2.51e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.51e-06	2.51e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.5e-06	2.5e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.5e-06	2.49e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.49e-06	2.48e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.49e-06	2.48e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.49e-06	2.48e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.49e-06	2.47e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.48e-06	2.47e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.48e-06	2.47e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.48e-06	2.47e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PPARG—type 2 diabetes mellitus	1.48e-06	2.47e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.48e-06	2.46e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-06	2.46e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.47e-06	2.45e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.47e-06	2.45e-05	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.46e-06	2.44e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.46e-06	2.42e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.46e-06	2.42e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—INS—type 2 diabetes mellitus	1.45e-06	2.42e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.45e-06	2.42e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.45e-06	2.41e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.45e-06	2.4e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.44e-06	2.4e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.43e-06	2.39e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.42e-06	2.36e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.41e-06	2.35e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.41e-06	2.35e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.4e-06	2.34e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.4e-06	2.33e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.4e-06	2.33e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.4e-06	2.32e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.4e-06	2.32e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.39e-06	2.32e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.39e-06	2.31e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.39e-06	2.31e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.39e-06	2.3e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.37e-06	2.29e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.37e-06	2.28e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.36e-06	2.26e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.35e-06	2.25e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.35e-06	2.25e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.35e-06	2.24e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.33e-06	2.22e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.33e-06	2.21e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.33e-06	2.21e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.3e-06	2.17e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.3e-06	2.16e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.28e-06	2.13e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.27e-06	2.12e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.27e-06	2.12e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.27e-06	2.12e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.27e-06	2.12e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.27e-06	2.12e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.26e-06	2.1e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.26e-06	2.1e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.25e-06	2.09e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.25e-06	2.08e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.23e-06	2.05e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.22e-06	2.04e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.21e-06	2.02e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.2e-06	2e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.2e-06	2e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.2e-06	2e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.2e-06	1.99e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.2e-06	1.99e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.19e-06	1.99e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.19e-06	1.98e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.19e-06	1.98e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.18e-06	1.97e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.18e-06	1.96e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.18e-06	1.96e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.17e-06	1.94e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-06	1.94e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.16e-06	1.93e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	1.16e-06	1.92e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.16e-06	1.92e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.15e-06	1.91e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.15e-06	1.91e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.14e-06	1.9e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.14e-06	1.9e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.14e-06	1.9e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.13e-06	1.88e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.12e-06	1.86e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.12e-06	1.86e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.12e-06	1.86e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.11e-06	1.84e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.1e-06	1.83e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.1e-06	1.83e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.1e-06	1.82e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.08e-06	1.8e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.07e-06	1.79e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.07e-06	1.78e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.07e-06	1.78e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.07e-06	1.78e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.07e-06	1.78e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.06e-06	1.76e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.05e-06	1.75e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.05e-06	1.75e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.05e-06	1.75e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.05e-06	1.74e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.04e-06	1.73e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.04e-06	1.72e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.03e-06	1.71e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.02e-06	1.7e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.02e-06	1.69e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.99e-07	1.66e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	9.86e-07	1.64e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.81e-07	1.63e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.74e-07	1.62e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.73e-07	1.62e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	9.68e-07	1.61e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	9.62e-07	1.6e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.62e-07	1.6e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	9.37e-07	1.56e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	9.32e-07	1.55e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	9.22e-07	1.53e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	9.18e-07	1.53e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	9.08e-07	1.51e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.93e-07	1.49e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	8.92e-07	1.48e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	8.92e-07	1.48e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.76e-07	1.46e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	8.52e-07	1.42e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	8.15e-07	1.36e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	8e-07	1.33e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.86e-07	1.31e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	7.85e-07	1.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	7.42e-07	1.24e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.4e-07	1.23e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	7.19e-07	1.2e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.88e-07	1.15e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.88e-07	1.15e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.82e-07	1.14e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.73e-07	1.12e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.29e-07	1.05e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.21e-07	1.03e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—type 2 diabetes mellitus	5.86e-07	9.75e-06	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	5.26e-07	8.75e-06	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	5.13e-07	8.54e-06	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.84e-07	8.05e-06	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.1e-07	6.82e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.16e-07	5.26e-06	CbGpPWpGaD
